Conditions: Severe Hypertriglyceridemia
Keywords: dyslipidemia hyperlipidemia omega-3 carboxylic acid
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 399
Healthy volunteers: no

Brief summary:
The primary objective of the study is to determine the efficacy of Epanova (omefas) compared to placebo in lowering serum triglycerides in subjects with severe hypertriglyceridemia.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None

Interventions: intervention 1: placebo intervention 2: omefas intervention 3: omefas intervention 4: omefas
Intervention descriptions: intervention 1: 4 capsules (1g) daily for 12 weeks intervention 2: 2 capsules (1g) + 2 placebo daily for 12 weeks intervention 3: 3 capsules (1g) + 1 placebo daily for 12 weeks intervention 4: 4 capsules (1g)daily for 12 weeks

Protocol document: